Skip to main content
. 2016 Feb 15;8(2):597–605.

Table 1.

Clinical characteristics of the participating patients in this study

Features Total AKAP4 P

Low High
Median Age (Range) 63.5 (42-77) 64.5 (43-77) 61.5 (42-74) 0.338
Gender 1
    Male/Female 22/8 11/4 11/4
Stage 0.696
    I+II 14 8 6
    III+IV 16 8 8
Lymph node status 0.028
    Negative 16 11 5
    Positive 14 4 10
AKAP4 mRNA expression 0.000
    Low 15 15 0
    High 15 0 15